Article Versions Notes

Zhang S, Liu Y, Liu X, Liu Y, Zhang J. Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis. Cancers. 2023; 15(4):1157. https://doi.org/10.3390/cancers15041157

Zhang, Shichao, Yan Liu, Xu Liu, Yingxue Liu, and Jin Zhang. 2023. "Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis" Cancers 15, no. 4: 1157. https://doi.org/10.3390/cancers15041157

Zhang, S., Liu, Y., Liu, X., Liu, Y., & Zhang, J. (2023). Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis. Cancers, 15(4), 1157. https://doi.org/10.3390/cancers15041157